[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Ferric Carboxymaltose Injection Market Growth 2023-2029

February 2023 | 97 pages | ID: G7799FF8B2DEEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Ferric carboxymaltose injection is an iron replacement product that is used to treat iron deficiency anemia (not enough iron in the blood) in patients with non-dialysis dependent chronic kidney disease (CKD), and in patients who cannot take iron supplements or who are taking iron supplements that did not work well.

LPI (LP Information)' newest research report, the “Ferric Carboxymaltose Injection Industry Forecast” looks at past sales and reviews total world Ferric Carboxymaltose Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Ferric Carboxymaltose Injection sales for 2023 through 2029. With Ferric Carboxymaltose Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ferric Carboxymaltose Injection industry.

This Insight Report provides a comprehensive analysis of the global Ferric Carboxymaltose Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ferric Carboxymaltose Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ferric Carboxymaltose Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ferric Carboxymaltose Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ferric Carboxymaltose Injection.

The global Ferric Carboxymaltose Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Ferric Carboxymaltose Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Ferric Carboxymaltose Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Ferric Carboxymaltose Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Ferric Carboxymaltose Injection players cover Daiichi Sankyo, Vifor Pharma, Hencer Pharma, Lupin, Weefsel Pharma, Apollo Pharmacy, Cipla and Bosch Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Ferric Carboxymaltose Injection market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • 2 ml
  • 10 ml
  • 20 ml
  • 15 ml
Segmentation by application
  • Hospital
  • Clinic
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Daiichi Sankyo
  • Vifor Pharma
  • Hencer Pharma
  • Lupin
  • Weefsel Pharma
  • Apollo Pharmacy
  • Cipla
  • Bosch Pharmaceuticals
Key Questions Addressed in this Report

What is the 10-year outlook for the global Ferric Carboxymaltose Injection market?

What factors are driving Ferric Carboxymaltose Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ferric Carboxymaltose Injection market opportunities vary by end market size?

How does Ferric Carboxymaltose Injection break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ferric Carboxymaltose Injection Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Ferric Carboxymaltose Injection by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Ferric Carboxymaltose Injection by Country/Region, 2018, 2022 & 2029
2.2 Ferric Carboxymaltose Injection Segment by Type
  2.2.1 2 ml
  2.2.2 10 ml
  2.2.3 20 ml
  2.2.4 15 ml
2.3 Ferric Carboxymaltose Injection Sales by Type
  2.3.1 Global Ferric Carboxymaltose Injection Sales Market Share by Type (2018-2023)
  2.3.2 Global Ferric Carboxymaltose Injection Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Ferric Carboxymaltose Injection Sale Price by Type (2018-2023)
2.4 Ferric Carboxymaltose Injection Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
2.5 Ferric Carboxymaltose Injection Sales by Application
  2.5.1 Global Ferric Carboxymaltose Injection Sale Market Share by Application (2018-2023)
  2.5.2 Global Ferric Carboxymaltose Injection Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Ferric Carboxymaltose Injection Sale Price by Application (2018-2023)

3 GLOBAL FERRIC CARBOXYMALTOSE INJECTION BY COMPANY

3.1 Global Ferric Carboxymaltose Injection Breakdown Data by Company
  3.1.1 Global Ferric Carboxymaltose Injection Annual Sales by Company (2018-2023)
  3.1.2 Global Ferric Carboxymaltose Injection Sales Market Share by Company (2018-2023)
3.2 Global Ferric Carboxymaltose Injection Annual Revenue by Company (2018-2023)
  3.2.1 Global Ferric Carboxymaltose Injection Revenue by Company (2018-2023)
  3.2.2 Global Ferric Carboxymaltose Injection Revenue Market Share by Company (2018-2023)
3.3 Global Ferric Carboxymaltose Injection Sale Price by Company
3.4 Key Manufacturers Ferric Carboxymaltose Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Ferric Carboxymaltose Injection Product Location Distribution
  3.4.2 Players Ferric Carboxymaltose Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR FERRIC CARBOXYMALTOSE INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Ferric Carboxymaltose Injection Market Size by Geographic Region (2018-2023)
  4.1.1 Global Ferric Carboxymaltose Injection Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Ferric Carboxymaltose Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Ferric Carboxymaltose Injection Market Size by Country/Region (2018-2023)
  4.2.1 Global Ferric Carboxymaltose Injection Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Ferric Carboxymaltose Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Ferric Carboxymaltose Injection Sales Growth
4.4 APAC Ferric Carboxymaltose Injection Sales Growth
4.5 Europe Ferric Carboxymaltose Injection Sales Growth
4.6 Middle East & Africa Ferric Carboxymaltose Injection Sales Growth

5 AMERICAS

5.1 Americas Ferric Carboxymaltose Injection Sales by Country
  5.1.1 Americas Ferric Carboxymaltose Injection Sales by Country (2018-2023)
  5.1.2 Americas Ferric Carboxymaltose Injection Revenue by Country (2018-2023)
5.2 Americas Ferric Carboxymaltose Injection Sales by Type
5.3 Americas Ferric Carboxymaltose Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ferric Carboxymaltose Injection Sales by Region
  6.1.1 APAC Ferric Carboxymaltose Injection Sales by Region (2018-2023)
  6.1.2 APAC Ferric Carboxymaltose Injection Revenue by Region (2018-2023)
6.2 APAC Ferric Carboxymaltose Injection Sales by Type
6.3 APAC Ferric Carboxymaltose Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Ferric Carboxymaltose Injection by Country
  7.1.1 Europe Ferric Carboxymaltose Injection Sales by Country (2018-2023)
  7.1.2 Europe Ferric Carboxymaltose Injection Revenue by Country (2018-2023)
7.2 Europe Ferric Carboxymaltose Injection Sales by Type
7.3 Europe Ferric Carboxymaltose Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ferric Carboxymaltose Injection by Country
  8.1.1 Middle East & Africa Ferric Carboxymaltose Injection Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Ferric Carboxymaltose Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Ferric Carboxymaltose Injection Sales by Type
8.3 Middle East & Africa Ferric Carboxymaltose Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ferric Carboxymaltose Injection
10.3 Manufacturing Process Analysis of Ferric Carboxymaltose Injection
10.4 Industry Chain Structure of Ferric Carboxymaltose Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Ferric Carboxymaltose Injection Distributors
11.3 Ferric Carboxymaltose Injection Customer

12 WORLD FORECAST REVIEW FOR FERRIC CARBOXYMALTOSE INJECTION BY GEOGRAPHIC REGION

12.1 Global Ferric Carboxymaltose Injection Market Size Forecast by Region
  12.1.1 Global Ferric Carboxymaltose Injection Forecast by Region (2024-2029)
  12.1.2 Global Ferric Carboxymaltose Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ferric Carboxymaltose Injection Forecast by Type
12.7 Global Ferric Carboxymaltose Injection Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Daiichi Sankyo
  13.1.1 Daiichi Sankyo Company Information
  13.1.2 Daiichi Sankyo Ferric Carboxymaltose Injection Product Portfolios and Specifications
  13.1.3 Daiichi Sankyo Ferric Carboxymaltose Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Daiichi Sankyo Main Business Overview
  13.1.5 Daiichi Sankyo Latest Developments
13.2 Vifor Pharma
  13.2.1 Vifor Pharma Company Information
  13.2.2 Vifor Pharma Ferric Carboxymaltose Injection Product Portfolios and Specifications
  13.2.3 Vifor Pharma Ferric Carboxymaltose Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Vifor Pharma Main Business Overview
  13.2.5 Vifor Pharma Latest Developments
13.3 Hencer Pharma
  13.3.1 Hencer Pharma Company Information
  13.3.2 Hencer Pharma Ferric Carboxymaltose Injection Product Portfolios and Specifications
  13.3.3 Hencer Pharma Ferric Carboxymaltose Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Hencer Pharma Main Business Overview
  13.3.5 Hencer Pharma Latest Developments
13.4 Lupin
  13.4.1 Lupin Company Information
  13.4.2 Lupin Ferric Carboxymaltose Injection Product Portfolios and Specifications
  13.4.3 Lupin Ferric Carboxymaltose Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Lupin Main Business Overview
  13.4.5 Lupin Latest Developments
13.5 Weefsel Pharma
  13.5.1 Weefsel Pharma Company Information
  13.5.2 Weefsel Pharma Ferric Carboxymaltose Injection Product Portfolios and Specifications
  13.5.3 Weefsel Pharma Ferric Carboxymaltose Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Weefsel Pharma Main Business Overview
  13.5.5 Weefsel Pharma Latest Developments
13.6 Apollo Pharmacy
  13.6.1 Apollo Pharmacy Company Information
  13.6.2 Apollo Pharmacy Ferric Carboxymaltose Injection Product Portfolios and Specifications
  13.6.3 Apollo Pharmacy Ferric Carboxymaltose Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Apollo Pharmacy Main Business Overview
  13.6.5 Apollo Pharmacy Latest Developments
13.7 Cipla
  13.7.1 Cipla Company Information
  13.7.2 Cipla Ferric Carboxymaltose Injection Product Portfolios and Specifications
  13.7.3 Cipla Ferric Carboxymaltose Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Cipla Main Business Overview
  13.7.5 Cipla Latest Developments
13.8 Bosch Pharmaceuticals
  13.8.1 Bosch Pharmaceuticals Company Information
  13.8.2 Bosch Pharmaceuticals Ferric Carboxymaltose Injection Product Portfolios and Specifications
  13.8.3 Bosch Pharmaceuticals Ferric Carboxymaltose Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Bosch Pharmaceuticals Main Business Overview
  13.8.5 Bosch Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Ferric Carboxymaltose Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Ferric Carboxymaltose Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 2 ml
Table 4. Major Players of 10 ml
Table 5. Major Players of 20 ml
Table 6. Major Players of 15 ml
Table 7. Global Ferric Carboxymaltose Injection Sales by Type (2018-2023) & (K Units)
Table 8. Global Ferric Carboxymaltose Injection Sales Market Share by Type (2018-2023)
Table 9. Global Ferric Carboxymaltose Injection Revenue by Type (2018-2023) & ($ million)
Table 10. Global Ferric Carboxymaltose Injection Revenue Market Share by Type (2018-2023)
Table 11. Global Ferric Carboxymaltose Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Ferric Carboxymaltose Injection Sales by Application (2018-2023) & (K Units)
Table 13. Global Ferric Carboxymaltose Injection Sales Market Share by Application (2018-2023)
Table 14. Global Ferric Carboxymaltose Injection Revenue by Application (2018-2023)
Table 15. Global Ferric Carboxymaltose Injection Revenue Market Share by Application (2018-2023)
Table 16. Global Ferric Carboxymaltose Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Ferric Carboxymaltose Injection Sales by Company (2018-2023) & (K Units)
Table 18. Global Ferric Carboxymaltose Injection Sales Market Share by Company (2018-2023)
Table 19. Global Ferric Carboxymaltose Injection Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Ferric Carboxymaltose Injection Revenue Market Share by Company (2018-2023)
Table 21. Global Ferric Carboxymaltose Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Ferric Carboxymaltose Injection Producing Area Distribution and Sales Area
Table 23. Players Ferric Carboxymaltose Injection Products Offered
Table 24. Ferric Carboxymaltose Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Ferric Carboxymaltose Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Ferric Carboxymaltose Injection Sales Market Share Geographic Region (2018-2023)
Table 29. Global Ferric Carboxymaltose Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Ferric Carboxymaltose Injection Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Ferric Carboxymaltose Injection Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Ferric Carboxymaltose Injection Sales Market Share by Country/Region (2018-2023)
Table 33. Global Ferric Carboxymaltose Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Ferric Carboxymaltose Injection Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Ferric Carboxymaltose Injection Sales by Country (2018-2023) & (K Units)
Table 36. Americas Ferric Carboxymaltose Injection Sales Market Share by Country (2018-2023)
Table 37. Americas Ferric Carboxymaltose Injection Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Ferric Carboxymaltose Injection Revenue Market Share by Country (2018-2023)
Table 39. Americas Ferric Carboxymaltose Injection Sales by Type (2018-2023) & (K Units)
Table 40. Americas Ferric Carboxymaltose Injection Sales by Application (2018-2023) & (K Units)
Table 41. APAC Ferric Carboxymaltose Injection Sales by Region (2018-2023) & (K Units)
Table 42. APAC Ferric Carboxymaltose Injection Sales Market Share by Region (2018-2023)
Table 43. APAC Ferric Carboxymaltose Injection Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Ferric Carboxymaltose Injection Revenue Market Share by Region (2018-2023)
Table 45. APAC Ferric Carboxymaltose Injection Sales by Type (2018-2023) & (K Units)
Table 46. APAC Ferric Carboxymaltose Injection Sales by Application (2018-2023) & (K Units)
Table 47. Europe Ferric Carboxymaltose Injection Sales by Country (2018-2023) & (K Units)
Table 48. Europe Ferric Carboxymaltose Injection Sales Market Share by Country (2018-2023)
Table 49. Europe Ferric Carboxymaltose Injection Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Ferric Carboxymaltose Injection Revenue Market Share by Country (2018-2023)
Table 51. Europe Ferric Carboxymaltose Injection Sales by Type (2018-2023) & (K Units)
Table 52. Europe Ferric Carboxymaltose Injection Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Ferric Carboxymaltose Injection Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Ferric Carboxymaltose Injection Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Ferric Carboxymaltose Injection Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Ferric Carboxymaltose Injection Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Ferric Carboxymaltose Injection Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Ferric Carboxymaltose Injection Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Ferric Carboxymaltose Injection
Table 60. Key Market Challenges & Risks of Ferric Carboxymaltose Injection
Table 61. Key Industry Trends of Ferric Carboxymaltose Injection
Table 62. Ferric Carboxymaltose Injection Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Ferric Carboxymaltose Injection Distributors List
Table 65. Ferric Carboxymaltose Injection Customer List
Table 66. Global Ferric Carboxymaltose Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Ferric Carboxymaltose Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Ferric Carboxymaltose Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Ferric Carboxymaltose Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Ferric Carboxymaltose Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Ferric Carboxymaltose Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Ferric Carboxymaltose Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Ferric Carboxymaltose Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Ferric Carboxymaltose Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Ferric Carboxymaltose Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Ferric Carboxymaltose Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Ferric Carboxymaltose Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Ferric Carboxymaltose Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Ferric Carboxymaltose Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Daiichi Sankyo Basic Information, Ferric Carboxymaltose Injection Manufacturing Base, Sales Area and Its Competitors
Table 81. Daiichi Sankyo Ferric Carboxymaltose Injection Product Portfolios and Specifications
Table 82. Daiichi Sankyo Ferric Carboxymaltose Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Daiichi Sankyo Main Business
Table 84. Daiichi Sankyo Latest Developments
Table 85. Vifor Pharma Basic Information, Ferric Carboxymaltose Injection Manufacturing Base, Sales Area and Its Competitors
Table 86. Vifor Pharma Ferric Carboxymaltose Injection Product Portfolios and Specifications
Table 87. Vifor Pharma Ferric Carboxymaltose Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Vifor Pharma Main Business
Table 89. Vifor Pharma Latest Developments
Table 90. Hencer Pharma Basic Information, Ferric Carboxymaltose Injection Manufacturing Base, Sales Area and Its Competitors
Table 91. Hencer Pharma Ferric Carboxymaltose Injection Product Portfolios and Specifications
Table 92. Hencer Pharma Ferric Carboxymaltose Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Hencer Pharma Main Business
Table 94. Hencer Pharma Latest Developments
Table 95. Lupin Basic Information, Ferric Carboxymaltose Injection Manufacturing Base, Sales Area and Its Competitors
Table 96. Lupin Ferric Carboxymaltose Injection Product Portfolios and Specifications
Table 97. Lupin Ferric Carboxymaltose Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Lupin Main Business
Table 99. Lupin Latest Developments
Table 100. Weefsel Pharma Basic Information, Ferric Carboxymaltose Injection Manufacturing Base, Sales Area and Its Competitors
Table 101. Weefsel Pharma Ferric Carboxymaltose Injection Product Portfolios and Specifications
Table 102. Weefsel Pharma Ferric Carboxymaltose Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Weefsel Pharma Main Business
Table 104. Weefsel Pharma Latest Developments
Table 105. Apollo Pharmacy Basic Information, Ferric Carboxymaltose Injection Manufacturing Base, Sales Area and Its Competitors
Table 106. Apollo Pharmacy Ferric Carboxymaltose Injection Product Portfolios and Specifications
Table 107. Apollo Pharmacy Ferric Carboxymaltose Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Apollo Pharmacy Main Business
Table 109. Apollo Pharmacy Latest Developments
Table 110. Cipla Basic Information, Ferric Carboxymaltose Injection Manufacturing Base, Sales Area and Its Competitors
Table 111. Cipla Ferric Carboxymaltose Injection Product Portfolios and Specifications
Table 112. Cipla Ferric Carboxymaltose Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Cipla Main Business
Table 114. Cipla Latest Developments
Table 115. Bosch Pharmaceuticals Basic Information, Ferric Carboxymaltose Injection Manufacturing Base, Sales Area and Its Competitors
Table 116. Bosch Pharmaceuticals Ferric Carboxymaltose Injection Product Portfolios and Specifications
Table 117. Bosch Pharmaceuticals Ferric Carboxymaltose Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Bosch Pharmaceuticals Main Business
Table 119. Bosch Pharmaceuticals Latest Developments

LIST OF FIGURES

Figure 1. Picture of Ferric Carboxymaltose Injection
Figure 2. Ferric Carboxymaltose Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ferric Carboxymaltose Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Ferric Carboxymaltose Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Ferric Carboxymaltose Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 2 ml
Figure 10. Product Picture of 10 ml
Figure 11. Product Picture of 20 ml
Figure 12. Product Picture of 15 ml
Figure 13. Global Ferric Carboxymaltose Injection Sales Market Share by Type in 2022
Figure 14. Global Ferric Carboxymaltose Injection Revenue Market Share by Type (2018-2023)
Figure 15. Ferric Carboxymaltose Injection Consumed in Hospital
Figure 16. Global Ferric Carboxymaltose Injection Market: Hospital (2018-2023) & (K Units)
Figure 17. Ferric Carboxymaltose Injection Consumed in Clinic
Figure 18. Global Ferric Carboxymaltose Injection Market: Clinic (2018-2023) & (K Units)
Figure 19. Global Ferric Carboxymaltose Injection Sales Market Share by Application (2022)
Figure 20. Global Ferric Carboxymaltose Injection Revenue Market Share by Application in 2022
Figure 21. Ferric Carboxymaltose Injection Sales Market by Company in 2022 (K Units)
Figure 22. Global Ferric Carboxymaltose Injection Sales Market Share by Company in 2022
Figure 23. Ferric Carboxymaltose Injection Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Ferric Carboxymaltose Injection Revenue Market Share by Company in 2022
Figure 25. Global Ferric Carboxymaltose Injection Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Ferric Carboxymaltose Injection Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Ferric Carboxymaltose Injection Sales 2018-2023 (K Units)
Figure 28. Americas Ferric Carboxymaltose Injection Revenue 2018-2023 ($ Millions)
Figure 29. APAC Ferric Carboxymaltose Injection Sales 2018-2023 (K Units)
Figure 30. APAC Ferric Carboxymaltose Injection Revenue 2018-2023 ($ Millions)
Figure 31. Europe Ferric Carboxymaltose Injection Sales 2018-2023 (K Units)
Figure 32. Europe Ferric Carboxymaltose Injection Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Ferric Carboxymaltose Injection Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Ferric Carboxymaltose Injection Revenue 2018-2023 ($ Millions)
Figure 35. Americas Ferric Carboxymaltose Injection Sales Market Share by Country in 2022
Figure 36. Americas Ferric Carboxymaltose Injection Revenue Market Share by Country in 2022
Figure 37. Americas Ferric Carboxymaltose Injection Sales Market Share by Type (2018-2023)
Figure 38. Americas Ferric Carboxymaltose Injection Sales Market Share by Application (2018-2023)
Figure 39. United States Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Ferric Carboxymaltose Injection Sales Market Share by Region in 2022
Figure 44. APAC Ferric Carboxymaltose Injection Revenue Market Share by Regions in 2022
Figure 45. APAC Ferric Carboxymaltose Injection Sales Market Share by Type (2018-2023)
Figure 46. APAC Ferric Carboxymaltose Injection Sales Market Share by Application (2018-2023)
Figure 47. China Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Ferric Carboxymaltose Injection Sales Market Share by Country in 2022
Figure 55. Europe Ferric Carboxymaltose Injection Revenue Market Share by Country in 2022
Figure 56. Europe Ferric Carboxymaltose Injection Sales Market Share by Type (2018-2023)
Figure 57. Europe Ferric Carboxymaltose Injection Sales Market Share by Application (2018-2023)
Figure 58. Germany Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Ferric Carboxymaltose Injection Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Ferric Carboxymaltose Injection Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Ferric Carboxymaltose Injection Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Ferric Carboxymaltose Injection Sales Market Share by Application (2018-2023)
Figure 67. Egypt Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Ferric Carboxymaltose Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Ferric Carboxymaltose Injection in 2022
Figure 73. Manufacturing Process Analysis of Ferric Carboxymaltose Injection
Figure 74. Industry Chain Structure of Ferric Carboxymaltose Injection
Figure 75. Channels of Distribution
Figure 76. Global Ferric Carboxymaltose Injection Sales Market Forecast by Region (2024-2029)
Figure 77. Global Ferric Carboxymaltose Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Ferric Carboxymaltose Injection Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Ferric Carboxymaltose Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Ferric Carboxymaltose Injection Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Ferric Carboxymaltose Injection Revenue Market Share Forecast by Application (2024-2029)


More Publications